Skip to main content

Table 2 In-hospital therapy and at discharge in patients with or without stroke

From: Immediate and one-year outcome of patients presenting with Acute Coronary Syndrome complicated by stroke: Findings from the 2ndGulf Registry of Acute Coronary Events (Gulf RACE-2)

  During admission At discharge
No stroke Stroke P value No stroke Stroke P value
(n = 7,874) (n = 56) (n = 78744) (n = 56)
Coronary angiography 32.6% 12.5%* 0.002    
Percutaneous coronary intervention 14.5% 5.4% 0.08    
Elective 10.2% 1.8% 0.42    
Urgent/Emergency PCI (UA/NSTEMI) 4.2% 3.6%     
Aspirin 98% 91% 0.001 93% 57% 0.001
β blockers 75% 46% 0.001 80% 38% 0.001
Clopidogrel 76% 55% 0.001 68% 38% 0.001
ACE inhibitors 25.6% 33.9% 0.16 72% 47% 0.001
Angiotensin receptor blockers 4.7% 1.8% 0.30 6.8% 1.8% 0.1
HMG-CoA reductase inhibitor 95% 89% 0.06 92% 58% 0.001
GPIIb/IIa inhibitors 7.8% 3.6% 0.25    
Thrombolytic therapy       
t-PA 3% 13% 0.09    
Streoptkinase 42% 40%     
Reteplase 44% 47%     
Tenektopase 11% 0%     
Unfractionated heparin 49.5% 33.9% 0.02    
LMWH (enoxaparin) 39.1% 21.4% 0.02    
  1. Data are expressed as percentage; STEMI = ST elevation myocardial infarction; NSTEMI = non ST elevation myocardial infarction; UA = unstable angina; LBBB = left bundle branch block; PCI = percutaneous coronary intervention; LVEF = left ventricular ejection fraction.